Condition
Acute Graft Versus Host Disease clinical trials and research
As of November 12, 2026, Find a Trial lists 13 Acute Graft Versus Host Disease clinical trials that are recruiting, at sites in 3 countries (most in China (9), United States (3), Mexico (1)). By phase: Phase 2 (4), Phase 3 (3), Phase 1 (2), Phase 1/2 (1). The most active sponsors are Anhui Provincial Hospital (2), First Affiliated Hospital of Zhejiang University (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 13Clinical trials
- 3Countries
Newest Acute Graft Versus Host Disease clinical trials
All recruiting trials (13)
-
Moxibustion with second-line treatment for steroid-refractory acute graft-versus-host disease after transplant
This study will test whether adding moxibustion to standard second-line drug therapy helps people aged 14–65 with steroid-refractory gastrointestinal acute GVHD after an allogeneic stem cell transplant.
-
Post-transplant dental cleaning to prevent chronic graft-versus-host disease
This will try a dental cleaning about 28 days after an allogeneic stem cell transplant to see if it lowers the chance of chronic graft-versus-host disease in adult transplant recipients.
-
First-line jaktinib plus corticosteroids for acute graft-versus-host disease
This trial will test whether adding jaktinib to standard steroids helps adults with grade II–IV acute graft-versus-host disease after an allogeneic stem cell transplant.
-
Timing of umbilical cord blood infusion and risk of acute graft-versus-host disease after transplant
This trial will test whether giving a single-unit unrelated umbilical cord blood transplant at different times of day changes the chance of acute graft-versus-host disease in people with malignant blood disorders who are in remission.
-
Ruxolitinib treatment for acute graft-versus-host disease
This study is testing if ruxolitinib can help people with acute graft-versus-host disease who haven't improved with regular steroid treatments.
-
Using human chorionic gonadotropin to treat acute graft versus host disease
This study is testing if adding a hormone called hCG to standard steroid treatment can help people with acute graft versus host disease feel better after their stem cell transplant.
-
Preventing severe acute graft‑versus‑host disease in high‑risk adults with an anti‑CD25 antibody
This trial will try a recombinant humanized anti‑CD25 antibody to prevent severe aGVHD in adults the daGOAT model flags as intermediate‑to‑high risk after allogeneic stem cell transplant.
-
Universal T-cell therapy for treating severe aGVHD
This study is testing a new type of T-cell therapy to see if it can help people with severe acute graft-versus-host disease who haven't responded to standard treatments after a stem cell transplant.
-
Investigating immune cells in acute graft-versus-host disease
This study is looking at how certain immune cells affect the development and progression of acute graft-versus-host disease in people who have had a stem cell transplant.
-
Timing the donor stem cell infusion to reduce acute graft-versus-host disease after donor blood stem cell transplant
This trial tests whether changing the clock time when donor peripheral blood stem cells are given can lower the risk and severity of acute graft-versus-host disease in people aged 12–60 having their first allogeneic peripheral blood stem cell transplant for nonmalignant blood disorders.
-
Mini-dose MTX combined with standard-dose steroids for treating acute GVHD
This study is testing if a low dose of methotrexate combined with standard steroids can help people with acute graft-versus-host disease feel better compared to just using the standard steroids alone.
-
Using leflunomide with steroids to treat acute graft-versus-host disease after stem cell transplant
This study is testing if adding leflunomide to steroid treatment can help people with acute graft-versus-host disease after a stem cell transplant feel better and reduce their symptoms.
-
Using fecal microbiota to treat gut acute graft-versus-host disease
This study is testing whether fecal microbiota transplantation can help improve gut symptoms in patients with acute graft-versus-host disease after stem cell transplantation.
Related topics
Quick answers
How many Acute Graft Versus Host Disease clinical trials are recruiting right now?
13, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (9 trials), United States (3 trials), Mexico (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4, Phase 3: 3, Phase 1: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.